Clinical Trial Update: Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating Angiwell-XR (ranolazine) for ischemic heart disease with chronic stable angina; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Stable Angina

Drugs mentioned

• Angiwell-XR (Ranolazine) (Ranolazine)

Snippet

Sponsor: OBS Pakistan | Conditions: Chronic Stable Angina | Phase 4 | Status: UNKNOWN